Perception of hypertension management by patients and doctors in Asia: potential to improve blood pressure control

Asia Pacific Family Medicine

Abdul Rashid Abdul Rahman³  Ji-Guang Wang²  Gary Mak Yiu Kwong⁴  Dante D Morales⁵  Piyamitr Sritara¹  Renan Sukmawan⁶ 

[1] Praram 9 Hospital, Bangkok, Thailand

[2] Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

[3] An Nur Specialist Hospital, No. 19 Medan Pusat Bandar 1 Section 9, Bandar Baru Bangi, 436550, Kajang, Malaysia

[4] Pro-Cardio Heart Disease & Stroke Prevention Centre, Tsim Sha Tsui, Hong Kong

[5] Department of Internal Medicine and Cardiology, Manila Doctors Hospital, Manila, Philippines

[6] Department of Cardiology and Vascular Medicine, University of Indonesia, Harapan Kita National Cardiovascular Center, Jakarta, Indonesia

关键词: Qualitative research;    Thailand;    Taiwan;    South Korea;    Philippines;    Malaysia;    Indonesia;    Hong Kong;    Hypertension;    Attitude to health;   

Others  :  1137346
DOI  :  10.1186/s12930-015-0018-3

 received in 2014-10-01, accepted in 2015-01-27,  发布年份 2015

【 摘 要 】

Background

Hypertension is one of the world’s most common health conditions and is a leading risk factor for mortality. Although blood pressure can be modified, there is a large proportion of patients whose blood pressure remains uncontrolled. The aim of this study, termed Edvantage 360°, was to gain a deeper understanding of hypertension management in Asia from the perspective of patients and doctors, and to propose strategies to improve blood pressure control.

Methods

Conducted in Hong Kong, Indonesia, Malaysia, the Philippines, South Korea, Taiwan, and Thailand, Edvantage 360° was a mixed-methods observational study that used both qualitative and quantitative elements: qualitative interviews and focus groups with patients (N = 110), quantitative interviews with patients (N = 709), and qualitative interviews with doctors (N = 85).

Results

This study found that, although there is good understanding of the causes and consequences of hypertension among Asian patients, there is a lack of urgency to control blood pressure. Doctors and patients have different expectations of each other and a divergent view on what constitutes successful hypertension management. We also identified a fundamental gap between the beliefs of doctors and patients as to who should be most responsible for the patients’ hypertension management. In addition, because patients find it difficult to comply with lifestyle modifications (often because of a decreased understanding of the changes required), adherence to medication regimens may be less of a limiting factor than doctors believe.

Conclusions

Doctors may provide better care by aligning with their patients on a common understanding of successful hypertension management. Doctors may also find it helpful to provide a more personalized explanation of any needed lifestyle modifications. The willingness of the doctor to adjust their patient interaction style to form a ‘doctor-patient team’ is important. In addition, we recommend that doctors should not attribute ineffectiveness of the treatment plan to patient non-adherence to medications, but rather adjust the medication regimen as needed.

【 授权许可】

   
2015 Rahman et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Kearney PM, Whelton M, Reynolds K, Whelton PK, He J: Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004, 22:11-9.
• [2]Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ: Comparative Risk Assessment Collaborating Group: Selected major risk factors and global and regional burden of disease. Lancet 2002, 360:1347-60.
• [3]Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, et al.: Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007, 25:73-9.
• [4]The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National Institutes of Health, United States. Available at http://www.nhlbi.nih.gov/guidelines/hypertension/jncintro.htm (accessed August 2014).
• [5]Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, et al.: ESH-ESC guidelines for the management of hypertension. Herz 2006, 31:331-8.
• [6]Hypertension: Clinical management of primary hypertension in adults. National Institute for Health and Clinical Excellence, United Kingdom. Available at http://www.nice.org.uk/guidance/cg127 (accessed August 2014).
• [7]Whelton PK, He J, Muntner P: Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 2004, 18:545-51.
• [8]Centers for Disease Control and Prevention: Vital signs: prevalence, treatment, and control of hypertension - United States, 1999–2002 and 2005–2008 MMWR Morb Mortal Wkly Rep 2011, 60:103-8.
• [9]Aekplakorn W, Sangthong R, Kessomboon P, Putwatana P, Inthawong R, Taneepanichskul S, et al.: Changes in prevalence, awareness, treatment and control of hypertension in Thai population, 2004–2009: Thai National Health Examination Survey III-IV. J Hypertens 2012, 30:1734-42.
• [10]Lee HS, Park YM, Kwon HS, Lee JH, Park YJ, Lim SY, et al.: Prevalence, awareness, treatment, and control of hypertension among people over 40 years old in a rural area of South Korea: The Chungju Metabolic Disease Cohort (CMC) Study. Clin Exp Hypertens 2010, 32:166-78.
• [11]Rampal L, Rampal S, Azhar MZ, Rahman AR: Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16,440 subjects. Public Health 2008, 122:11-8.
• [12]Wu Y, Tai ES, Heng D, Tan CE, Low LP, Lee J: Risk factors associated with hypertension awareness, treatment, and control in a multi-ethnic Asian population. J Hypertens 2009, 27:190-7.
• [13]Marshall IJ, Wolfe CD, McKevitt C: Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ 2012, 345:e3953.
• [14]Anthony H, Valinsky L, Inbar Z, Gabriel C, Varda S: Perceptions of hypertension treatment among patients with and without diabetes. BMC Fam Pract 2012, 13:24. BioMed Central Full Text
• [15]Perkovic V, Huxley R, Wu Y, Prabhakaran D, MacMahon S: The burden of blood pressure-related disease: a neglected priority for global health. Hypertension 2007, 50:991-7.
• [16]Woodward M, Huxley H, Lam TH, Barzi F, Lawes CM, Ueshima H, et al.: A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur J Cardiovasc Prev Rehabil 2005, 12:484-91.
• [17]Liu LS, Caguioa ES, Park CG, Quek DK, Saito I, Venketasubramanian N, et al.: Reducing stroke risk in hypertensive patients: Asian Consensus Conference recommendations. Int J Stroke 2006, 1:150-7.
• [18]Jokisalo E, Kumpusalo E, Enlund H, Takala J: Patients’ perceived problems with hypertension and attitudes towards medical treatment. J Hum Hypertens 2001, 15:755-61.
• [19]Volpe M, Dedhiya SD: Physicians, patients, and public knowledge and perception regarding hypertension and stroke: a review of survey studies. Curr Med Res Opin 2006, 22:1319-30.
• [20]Vathesatogkit P, Sritara P, Kimman M, Hengprasith B, E-Shyong T, Wee HL, et al.: Associations of lifestyle factors, disease history and awareness with health-related quality of life in a Thai population. PLoS One 2012, 7:e49921.
• [21]Palatini P: Ambulatory and home blood pressure measurement: complementary rather than competitive methods. Hypertension 2012, 59:2-4.
• [22]Abdullah A, Othman S: The influence of self-owned home blood pressure monitoring (HBPM) on primary care patients with hypertension: a qualitative study. BMC Fam Pract 2011, 12:143. BioMed Central Full Text
• [23]Consoli SM, Lemogne C, Levy A, Pouchain D, Laurent S: Physicians’ degree of motivation regarding their perception of hypertension, and blood pressure control. J Hypertens 2010, 28:1330-9.
• [24]Ogedegbe G: Barriers to optimal hypertension control. J Clin Hypertens (Greenwich) 2008, 10:644-6.
• [25]Hyman DJ, Pavlik VN: Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 2000, 160:2281-6.
• [26]Saito I, Kawabe H, Tsujioka M, Hirose H, Shibata H: Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. First Japanese Society of Hypertension. Hypertens Res 2002, 25:175-8.
• [27]Wexler R, Elton T, Taylor CA, Pleister A, Feldman D: Physician reported perception in the treatment of high blood pressure does not correspond to practice. BMC Fam Pract 2009, 10:23. BioMed Central Full Text
• [28]Chung N, Baek S, Chen MF, Liau CS, Park CG, Park J, et al.: Expert recommendations on the challenges of hypertension in Asia. Int J Clin Pract 2008, 62:1306-12.
• [29]Hassan NB, Hasanah CI, Foong K, Naing L, Awang R, Ismail SB, et al.: Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens 2006, 20:23-9.